Pediatric invasive mucormycosis cured with high dose liposomal amphotericin B.
Tuberk Toraks
; 60(4): 375-9, 2012.
Article
em En
| MEDLINE
| ID: mdl-23289469
ABSTRACT
Amphotericin B remains the mainstay medical treatment of pulmonary mucormycosis. Optimal dose is not defined. We described a case of pulmonary mucormycosis, which had been treated with 42.55 g (during to 45 weeks) liposomal amphotericin B. In medical literature this case is one of the highest doses of lyposomal amphotericin B administered to a pediatric patient.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Anfotericina B
/
Mucormicose
/
Antifúngicos
Limite:
Child
/
Humans
/
Male
Idioma:
En
Revista:
Tuberk Toraks
Ano de publicação:
2012
Tipo de documento:
Article
País de afiliação:
Turquia